G
Gennex Laboratories
GENNEX Share Price
Healthcare10.31
BSE
as on 23 Apr 2026 at 15:29
Market Cap
₹251 Cr
PE Ratio
12.90
ROCE
11.82%
GENNEX Fundamentals
Company Valuation
Market Cap (₹ Cr.)
251
PE Ratio
12.90
PB Ratio
1.19
Dividend Yield
-
ROE
9.31%
ROCE
11.82%
Book Value (₹)
8.79
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Jun 2025 | Jul 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 19.83% | 23.62% | 23.62% | 23.62% | 23.63% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 61.90% | 58.97% | 59.34% | 56.47% | 55.79% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GENNEX Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
531739
NSE Scrip Name
GENNEX
ISIN
INE509C01026



